Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Olle Melander

Principal investigator

Default user image.

Atrial Natriuretic Peptide in the high normal range is associated with lower prevalence of insulin resistance.

Author

  • Amra Jujic
  • Peter Nilsson
  • Margaretha Persson
  • Jens Juul Holst
  • Signe Sørensen Torekov
  • Valeriya Lyssenko
  • Leif Groop
  • Olle Melander
  • Martin Magnusson

Summary, in English

Context We have previously shown that high levels of atrial natriuretic peptides (ANP) are associated with decreased risk of future diabetes development; however, the mechanism behind this relationship is not fully understood.

Department/s

  • Cardiovascular Research - Hypertension
  • Internal Medicine - Epidemiology
  • Genomics, Diabetes and Endocrinology
  • Department of Clinical Sciences, Malmö
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2016

Language

English

Pages

1372-1380

Publication/Series

The Journal of clinical endocrinology and metabolism

Volume

101

Issue

4

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Cardiac and Cardiovascular Systems
  • Endocrinology and Diabetes

Status

Published

Project

  • The use of Genomics and Proteomics for the Detection and Prevention of Cardiometabolic Disease

Research group

  • Cardiovascular Research - Hypertension
  • Internal Medicine - Epidemiology
  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 1945-7197